MedPath

Sulfasalazine

Sulfasalazine Tablets, USP

Approved
Approval ID

bf5137fe-60ed-4497-8521-eeb0a684fabf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 16, 2023

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sulfasalazine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71610-706
Application NumberNDA007073
Product Classification
M
Marketing Category
C73605
G
Generic Name
Sulfasalazine
Product Specifications
Route of AdministrationORAL
Effective DateMay 16, 2023
FDA Product Classification

INGREDIENTS (5)

SULFASALAZINEActive
Quantity: 500 mg in 1 1
Code: 3XC8GUZ6CB
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sulfasalazine - FDA Drug Approval Details